Clinical Trial
New data from hyponatremia treatment trials released
Published in Medical Letter on the CDC and FDA, December 5th, 2004
Hyponatremia is a potentially life-threatening condition that occurs when the body's sodium level falls below normal. The results of two, phase III studies were presented this weekend at the annual meeting of the American Society of Nephrology.
Conivaptan is a novel drug that blocks both V1A and V2 vasopressin receptors, increasing serum sodium and urine output without increasing sodium loss. This effect, known as...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- AIDS/HIV Therapy
Providers in Brazil following guidelines for management of HIV patients - Ebola Virus
Blood samples from fatal and nonfatal cases of Ebola infection analyzed - Environmental Health
Metabolite of pesticide methoxychlor reduces testosterone formation - Hepatitis B
Outbreak of hepatitis B in drug users causes high mortality - Sexually Transmitted Disease
Internet Alert Project spreads word about high-risk sexual activities - AIDS/HIV Transmission
Model of perinatal transmission of SHIV in macaques developed - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
